About Us
Creative Diagnostics's CamNB™ nanobody development platform offers customized nanobodies with high affinity and selectivity towards tumor-associated antigens, ensuring robust performance in imaging modalities such as PET, SPECT, and fluorescence imaging. Our comprehensive suite of services encompasses antigen discovery, nanobody generation, optimization, conjugation to imaging probes, and preclinical validation studies, facilitating seamless integration into diagnostic workflows.
With a commitment to advancing precision medicine, our nanobody-based solutions hold tremendous potential for enhancing early detection, monitoring therapeutic response, and guiding personalized treatment strategies in oncology. Partner with us to unlock the transformative power of nanobodies in revolutionizing tumor imaging and diagnosis.